MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid?

(MedPage Today) -- The FDA is currently reviewing midomafetamine capsules -- an MDMA-containing therapeutic -- as a potential post-traumatic stress disorder treatment to be used in combination with psychological intervention based on the phase...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news